Wednesday, December 3, 2025

3 Reasons to Sell BBWI and 1 Stock to Buy Instead

Shareholders of Bath and Body Works would probably like to forget the past six months even happened. The stock dropped 31% and now trades at $23.05. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

Is now the time to buy Bath and Body Works, or should you be careful about including it in your portfolio? Get the full stock story straight from our expert analysts, it’s free for active Edge members.

Despite the more favorable entry price, we’re sitting this one out for now. Here are three reasons we avoid BBWI and a stock we’d rather own.

Same-store sales show the change in sales for a retailer’s e-commerce platform and brick-and-mortar shops that have existed for at least a year. This is a key performance indicator because it measures organic growth.

Bath and Body Works’s demand has been shrinking over the last two years as its same-store sales have averaged 2.1% annual declines.

Bath and Body Works Same-Store Sales Growth
Bath and Body Works Same-Store Sales Growth

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite.

Over the next 12 months, sell-side analysts expect Bath and Body Works’s revenue to rise by 2.1%, a deceleration versus This projection is underwhelming and indicates its products will see some demand headwinds.

Analyzing the long-term change in earnings per share (EPS) shows whether a company’s incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions.

Bath and Body Works’s unimpressive 8.5% annual EPS growth over the last six years aligns with its revenue performance. This tells us it maintained its per-share profitability as it expanded.

Bath and Body Works Trailing 12-Month EPS (GAAP)
Bath and Body Works Trailing 12-Month EPS (GAAP)

Bath and Body Works isn’t a terrible business, but it doesn’t pass our bar. Following the recent decline, the stock trades at 6.5× forward P/E (or $23.05 per share). While this valuation is reasonable, we don’t really see a big opportunity at the moment. We’re pretty confident there are superior stocks to buy right now. We’d recommend looking at one of Charlie Munger’s all-time favorite businesses.

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Source link

Hot this week

Rio Tinto Hits the Brakes on Lithium in Strategy Shakeup

Rio Tinto is streamlining operations and...

The Hitchhiker’s Guide to the Tennessee special election results

NEWYou can now listen to Fox News articles! ...

Alphabet Just Delivered Bad News for Nvidia Stock Investors

Google parent company, Alphabet, is coming for Nvidia in...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img